UNITY DX Cornea Study
ConditionTomography
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age22+
SponsorAlcon Research
About this trial
The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of corneal and epithelial thickness maps will be evaluated.
Eligibility criteria
Qualifiers
Able to understand and sign an Institutional Review Board approved informed consent form.
Willing and able to attend all scheduled study visits as required per protocol.
Identified by the investigator as having normal corneas or abnormal corneas per protocol-specified criteria.
Other protocol-specified inclusion criteria may apply.
Disqualifiers
Unable to fixate due to nystagmus or other eye movement abnormality, such as significant strabismus.
Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study.
Active ocular infection or inflammation.
Other protocol-specified exclusion criteria may apply.
Trial design
Treatments tested in this trial
- UNITY DX
- ANTERION
Treatment groups
110 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov